OLD General Pharmacy Policies

The files below were archived 09/2018

Table of Contents

I. General Policies and Procedures

A. Organization Aspects
IA1 – Provider Pharmacy Requirements
IA2 – Consultant Pharmacist Services Provider Requirements
IA3 – Infusion Therapy Products Provider Requirements
IA4 – Arrangements With Noncontract Pharmacy

B. Medication Orders
IB1 – Non-controlled Medication Order Documentation
IB2 – Controlled Substance Prescriptions
IB3 – Time Limited Orders
IB4 – Standing Orders

C. Medication Ordering and Receiving from Pharmacy
IC1 – Pharmacy Hours and Delivery Schedule
IC2 – Pharmacy Delivery
IC3 – Ordering and Receiving Non-Controlled Medications
IC4 – Receiving Controlled Substances
IC5 – Emergency Pharmacy Service and Emergency Kits
IC6 – Multiple Source Drug Products
IC7 – Drug Information
IC8 – House Supplied Floor Stock Medications
IC9 – Material Safety Data Sheets MSDS
IC10 – Medication Labels
IC11 – Medication Packaging
IC12 – Medications Brought to the Facility By a Resident or Responsible Party
IC13 – Approved Medications
IC14 – Personnel Authorized To Handle Medications in the Facility

D. Medication Storage in the Facility
ID1 – Storage of Medications
ID2 – Controlled Substance Storage
ID3 – Bedside Medication Storage

E. Disposal of Medications and Medication-Related Supplies
IE1 – Controlled Substance Disposal
IE2 – Discharge With Medications
IE3 – Discontinued Medications
IE4 – Returning Medications To Pharmacy
IE5 – Medication Destruction
IE6 – Syringe and Needle Disposal
IE7 – EPA Pharmaceutical Waste Storage and Disposal

F. Miscellaneous Special Situations
IF1 – Out On Pass Medications Leave of Absence LOA
IF2 – Use of Investigational Medications
IF3 – FDA Risk Evaluation and Medication Safety REMS Medication Guides
IF4 – Medications Not Covered by Third Party Payers Formulary Approval and Therapeutic Substitutions Upon Approval By Physician
IF5 – Medications Brought to the Facility by Physicians or-Residents or Family Members
IF6 – Drug Product Defect Reporting
IF7 – Drug Product Recalls
IF8 – Influenza and Pneumococcal Disease Prevention
IF9 – Box Warning Medications
IF10 – Unavailable Medications
IF11 – Pharmacist Physician Collaborative Care Agreement
IF12 – not provided
IF13 – Oral Vancomycin

II. Medication Administration

A. Preparation and General Guidelines
IIA1 – Equipment and Supplies for Administering
IIA2 – Medication Administration
IIA3 – Vials and Ampules of-Injectable Medications
IIA4 – Infusion Therapy Products General Information
IIA5 – Reconstitution of Medication for Parenteral Administration
IIA6 – Preparation of Emergency or Short Stability Infusion Therapy Products
IIA7 – Controlled Substances
IIA8 – Irrigation Solutions
IIA9 – General Guidelines for Administering Medication via Enteral Tube
IIA10 – Self Administration of Medications
IIA11 – Automated Dispensing Machine for First Dose and Emergency Medications Capsa First Dose Machine

B. Specific Medication Administration
IIB1 – Administration Procedures for All Medications
IIB2 -Oral Medication Administration
IIB3 – Sublingual Buccal and Transmucosal Medication Administration
IIB4- Nasal Administration
IIB5 – Eye Drop Administration
IIB6 – Eye Ointment and Gel Administration
IIB7 – Ear Drop Administration
IIB8 – Oral Inhalation Administration
IIB9 – Rectal Suppository Administration
IIB10 – Rectal Enema Administration
IIB11 – Vaginal Medication Administration
IIB12 – Enteral Tube Medication Administration
IIB13 – Transdermal Drug Delivery System Patch Application
IIB14 – Injectable Medication Administration
IIB15 – Infusion Therapy Medication Administration Medications Added to Infusion Preparations by the Nurse in the Facility
IIB16 – Topical Medication Administration

III. Medication Monitoring

A. Consultant Pharmacist Reports
IIIA1 – Medication Regimen Review
IIIA2 – Documentation and Communication of Consultant Pharmacist Recommendations

B. Medication Monitoring and Management
IIIB1 – Monitoring of Medication Administration
IIIB2 – Medication Management
IIIB3 – Preventing and Detecting Adverse Consequences and Medication Errors

Appendix
Full MACRX Facility Policy and Procedures Document
All Pharmacy Forms and Guides

The files below were archived in October 2016
Table of Contents

I. General Policies and Procedures
A. Organization Aspects
IA1 – Provider Pharmacy Requirements
IA2 – Consultant Pharmacist Services Provider
IA3 – Infusion Therapy Products Provider Requirements

B. Medication Orders
IB1 – Non-Controlled Medication Order Documentation
IB2 – Controlled Substance Prescriptions
IB3 – Time Limited Orders
IB4 – Standing Orders (Optional)

C. Medication Ordering and Receiving from Pharmacy
IC1 – Pharmacy Hours and Delivery Schedule
IC2 – Pharmacy Delivery
IC3 – Ordering and Receiving Non-Controlled Medications from the Dispensing Pharmacy
IC4 – Receiving Controlled Substances
IC5 – Emergency Pharmacy Service and Emergency Kits
IC6 – Multiple Source Drug Products
IC7 – Drug Information
IC8 – House-Supplied (Floor Stock) Medications
IC9 – Material Safety Data Sheets (MSDS)
IC10 – Medication Labels
IC11 – Medication Packaging
IC12 – Medications Brought to the Facility by a Resident or Responsible Party
IC13 – Approved Medications
IC14 – Personal Authorized to Handle Medications in the Facility

D. Medication Storage in the Facility
ID1 – Storage of Medications
ID2 – Controlled Substance Storage
ID3 – Bedside Medication Storage<

E. Disposal of Medications and Medication-Related Supplies
IE7 – EPA Pharmaceutical Waste Storage and Disposal (Optional)
IE1 – Controlled Substance Disposal
IE2 – Discharge With Medications
IE3 – Discontinued Medications
IE4 – Returning Medications to Pharmacy
IE5 – Medication Destruction
IE6 – Syringe and Needle Disposal

F. Miscellaneous Special Situations
IF12 – Collaborative Care Agreement (Optional)
IF1 – Out-On-Pass Medications – Leave of Absence (LOA)
IF2 – Use of Investigational Medications
IF3 – FDA Risk Evaluation and Medication Safety (REMS) Medication Guides
IF4 – Medications Not Covered by Third-Party Payers, Formulary Approval and Therapeutic Substituions Upon Approval by Tthe Physician
IF5 – Medications Brought to the Facility by Physicians or Resident or Family Members
IF6 – Drug Product Defect Reporting
IF7 – Drug Product Recalls
IF8 – Influenza and Pneumococcal Disease Prevention
IF10 – Box Warning Medications
IF11 – Unavailable Medications

II. Medication Administration
A. Preparation and General Guidelines
IIA11 – Automated Dispensing Machine for First Dose and Emergency Medications
IIA1 – Equipment and Supplies for Administering Medications
IIA2 – Medication Administration
IIA3 – Vials of Ampules of Injectable Medications
IIA4 – Infusion Therapy Products – General Information
IIA5 – Reconstitution of Medication for Parenteral Administration
IIA6 – Preparation of Emergency or Short-Stability Infusion Therapy Products
IIA7 – Controlled Substances
IIA8 – Irrigation Solutions
IIA9 – General Guidelines for Administering Medication Via Enteral Tube
IIA10 – Self-Administration of Medications

B. Specific Medication Administration
IIB1 – Administration Procedures For All Medications
IIB2 – Oral Medication Administration
IIB3 – Sublingual, Buccal, and Transmucosal Medication Administration
IIB4 – Nasal Administration
IIB5 – Eye Drop Administration
IIB6 – Eye Ointment and Gel Administration
IIB7 – Ear Drop Administration
IIB8 – Oral Inhalation Administration
IIB9 – Rectal Suppository Administration
IIB10 – Rectal Enema Administration
IIB11 – Vaginal Medication Administration
IIB12 – Enteral Tube Medication Administration
IIB13 – Transdermal Drug Delivery System (Patch) Application
IIB14 – Injectable Medication Administration
IIB15 – Infusion Therapy Medication Administration- Medications Added to Infusion Preparations by the Nurse in the Facility
IIB16 – Topical Medication Administration

III. Medication Monitoring
A. Consultant Pharmacist Reports
IIIA1 – Medication Regimen Review
IIIA2 – Documentation and Communication of Consultant Pharmacist Recommendations

B. Medication Monitoring and Management
IIIB1 – Monitoring of Medication Administration
IIIB2 – Medication Management
IIIB3 – Preventing and Detecting Adverse Consequences and Medication Errors

MAC Rx Facility Policy & Procedures full original document